Changchun Bcht Biotechnology Co.
Clinical trials sponsored by Changchun Bcht Biotechnology Co., explained in plain language.
-
MRNA vaccine takes on genital herpes in first human trial
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis early-stage study tests an mRNA vaccine designed to prevent genital herpes caused by HSV-2. About 144 healthy adults aged 18-55 will receive different doses to check safety and immune response. The vaccine aims to train the body to fight the virus, potentially stopping infec…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 02, 2026 17:02 UTC
-
Nasal spray flu vaccine: how well does it protect kids?
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis study looks at how the nasal spray flu vaccine works in children and teens aged 3 to 17. Researchers will measure special antibodies in the nose to see how the body fights the flu. The goal is to understand the immune response better and improve future vaccines.
Phase: PHASE4 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 02, 2026 17:02 UTC
-
New rabies vaccine passes first safety check in small study
Prevention ENROLLING_BY_INVITATIONThis early-stage study is testing whether a new freeze-dried rabies vaccine is safe for people aged 10 to 60. Eighty healthy volunteers will receive the vaccine and be monitored for side effects for 30 days. The goal is to prevent rabies, not to treat it after exposure.
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: Prevention
Last updated May 01, 2026 16:01 UTC
-
New rabies vaccine schedule put to the test in massive trial
Prevention ENROLLING_BY_INVITATIONThis study tests a new version of the rabies vaccine to see if different timing of shots works as well as the standard schedule. About 3,000 healthy people aged 10 to 60 will take part. Researchers will measure how many people develop protective antibodies and check for side effe…
Phase: PHASE3 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: Prevention
Last updated Apr 26, 2026 20:02 UTC